Healthequity (HQY) Cash from Financing Activities (2013 - 2026)

Healthequity's Cash from Financing Activities history runs 14 years deep, the most recent figure standing at -$137.2 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities fell 142.16% year-over-year to -$137.2 million; the TTM figure through Apr 2026 stood at -$467.5 million (down 819.33% YoY), while the FY2026 annual figure was -$387.0 million, down 772.22% from the prior year.
• Cash from Financing Activities was -$137.2 million for Q2 2026 at Healthequity, down from -$99.8 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $176.6 million in Q3 2024 to a low of -$137.2 million in Q2 2026.
• Historically, Cash from Financing Activities has averaged -$28.8 million across 5 years, with a median of -$3.2 million in 2022.
• Biggest YoY gain for Cash from Financing Activities was 8295.68% in 2024; the steepest drop was 4163.86% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$1.1 million in 2022, then soared by 285.21% to $2.0 million in 2023, then slumped by 4163.86% to -$82.4 million in 2024, then plunged by 48.51% to -$122.4 million in 2025, then decreased by 12.08% to -$137.2 million in 2026.
• The last three Cash from Financing Activities figures came in at -$137.2 million (Q2 2026), -$99.8 million (Q1 2026), and -$122.4 million (Q4 2025), per Business Quant data.